
Fertility is an important aspect of a woman’s overall health, and understanding it early can help in better planning for the future. One of the key tools used today in evaluating fertility potential is the Anti-Müllerian Hormone (AMH) test. In this blog, Dr. Mansi Gupta explains the role of AMH in fertility assessment, what the results mean, and how it can guide reproductive decisions.
Anti-Müllerian Hormone (AMH) is a hormone produced by small follicles in the ovaries. These follicles contain immature eggs, and the level of AMH in the blood reflects the number of eggs a woman has, also known as her ovarian reserve.
According to Dr. Mansi Gupta, AMH is one of the most reliable markers used to estimate ovarian reserve and assess reproductive potential.
AMH plays a crucial role in helping doctors understand a woman’s fertility status. It is particularly useful because:
Dr. Mansi Gupta emphasizes that while AMH does not predict the exact ability to conceive naturally, it offers valuable information about egg quantity.
The AMH test is a simple blood test that can be done at any time during the menstrual cycle. Unlike other hormone tests, it does not fluctuate significantly throughout the cycle.
Dr. Mansi Gupta recommends this test for women who are planning pregnancy, facing difficulty conceiving, or considering fertility preservation options.
AMH levels are measured in nanograms per milliliter (ng/mL), and the values can vary depending on age and individual factors.
Dr. Mansi Gupta advises that AMH results should always be interpreted along with other clinical findings for accurate assessment.
Age remains one of the most important factors in fertility. While AMH gives an estimate of egg quantity, it does not measure egg quality.
Dr. Mansi Gupta highlights that AMH should be seen as part of a broader fertility evaluation, not the sole determinant.
AMH is widely used in planning assisted reproductive treatments such as IVF.
With guidance from Dr. Mansi Gupta, AMH testing helps tailor treatment plans to improve success rates and safety.
Women with Polycystic Ovary Syndrome (PCOS) often have higher AMH levels due to increased number of follicles.
Dr. Mansi Gupta explains that while high AMH may seem beneficial, in PCOS it reflects hormonal imbalance rather than improved fertility.
While AMH is a valuable tool, it has certain limitations:
Dr. Mansi Gupta emphasizes that AMH should be used alongside ultrasound scans and other hormone tests for a complete picture.
AMH testing may be recommended for:
Consulting Dr. Mansi Gupta can help determine whether this test is appropriate based on individual health goals.
While AMH levels cannot be significantly increased, overall fertility can be supported through healthy lifestyle choices:
Dr. Mansi Gupta encourages proactive fertility planning and early evaluation for better outcomes.
Q: Can AMH levels predict pregnancy success?
A: No, AMH indicates egg quantity but does not guarantee pregnancy success.
Q: Is AMH testing necessary for all women?
A: Not always. It is recommended based on individual fertility concerns.
Q: Can AMH levels change over time?
A: Yes, AMH levels naturally decline with age.
Q: Is low AMH equal to infertility?
A: No, women with low AMH can still conceive naturally.
Q: When is the best time to take an AMH test?
A: It can be done at any time during the menstrual cycle.
The AMH test has become an essential part of modern fertility assessment. It provides valuable insights into ovarian reserve and helps guide both natural conception planning and assisted treatments.
However, as Dr. Mansi Gupta explains, AMH is just one piece of the puzzle. A comprehensive approach that includes age, medical history, and additional tests is necessary for accurate fertility evaluation.
If you are planning a pregnancy or have concerns about fertility, consulting an expert like Dr. Mansi Gupta can help you make informed and confident decisions.